SGK
Steigerwald Gordon & Koch Portfolio holdings
AUM
$948M
This Quarter Return
+9.2%
1 Year Return
+17.35%
3 Year Return
+62.97%
5 Year Return
+126.95%
10 Year Return
+248.69%
AUM
$917M
AUM Growth
+$917M
(+11%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
2.52%
Top 10 Holdings %
Top 10 Hldgs %
32.76%
Holding
131
New
8
Increased
73
Reduced
20
Closed
3
Top Buys
| 1 |
Pfizer
PFE
|
$1.21M |
| 2 |
McKesson
MCK
|
$1.09M |
| 3 |
Zoetis
ZTS
|
$1.02M |
| 4 |
DuPont de Nemours
DD
|
$1.01M |
| 5 |
RTX Corp
RTX
|
$915K |
Top Sells
| 1 |
Palantir
PLTR
|
$372K |
| 2 |
Intel
INTC
|
$253K |
| 3 |
Tesla
TSLA
|
$206K |
| 4 |
Boeing
BA
|
$193K |
| 5 |
Dick's Sporting Goods
DKS
|
$177K |
Sector Composition
| 1 | Technology | 26.42% |
| 2 | Healthcare | 18.34% |
| 3 | Industrials | 12.33% |
| 4 | Financials | 12% |
| 5 | Consumer Staples | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Capital One
COF
$142B
| $308K | 0.03% |
2,060
| – | – |
|
102
Starbucks
SBUX
$99.2B
| $307K | 0.03% |
3,152
+22
| +0.7% | +$2.15K |
|
103
iShares Core MSCI EAFE ETF
IEFA
$149B
| $298K | 0.03% |
+3,817
| New | +$298K |
|
104
Goldman Sachs
GS
$221B
| $289K | 0.03% |
584
+140
| +32% | +$69.4K |
|
105
Cigna
CI
$80.2B
| $287K | 0.03% |
828
| – | – |
|
106
CSX Corp
CSX
$60.2B
| $278K | 0.03% |
8,058
+1
| +0% | +$35 |
|
107
iShares MSCI EAFE ETF
EFA
$65.4B
| $262K | 0.03% |
3,138
-200
| -6% | -$16.7K |
|
108
Nike
NKE
$110B
| $262K | 0.03% |
2,961
-73
| -2% | -$6.46K |
|
109
Hubbell
HUBB
$22.8B
| $259K | 0.03% |
604
| – | – |
|
110
Bank of America Series L
BAC.PRL
$3.85B
| $255K | 0.03% |
200
| – | – |
|
111
Qualcomm
QCOM
$170B
| $254K | 0.03% |
1,496
+1
| +0.1% | +$170 |
|
112
Comcast
CMCSA
$125B
| $254K | 0.03% |
6,085
| – | – |
|
113
Schwab US Large- Cap ETF
SCHX
$58.8B
| $250K | 0.03% |
11,067
+1,500
| +16% | +$33.9K |
|
114
Utilities Select Sector SPDR Fund
XLU
$20.8B
| $247K | 0.03% |
3,062
| – | – |
|
|
115
Bank of America
BAC
$371B
| $246K | 0.03% |
6,200
+2
| +0% | +$79 |
|
116
Union Pacific
UNP
$132B
| $243K | 0.03% |
986
| – | – |
|
117
ASML
ASML
$290B
| $242K | 0.03% |
291
-10
| -3% | -$8.33K |
|
118
Novartis
NVS
$248B
| $241K | 0.03% |
2,091
+95
| +5% | +$10.9K |
|
119
Linde
LIN
$221B
| $237K | 0.03% |
497
| – | – |
|
120
Technology Select Sector SPDR Fund
XLK
$83.6B
| $229K | 0.03% |
1,015
| – | – |
|
121
Keysight
KEYS
$28.4B
| $223K | 0.02% |
+1,401
| New | +$223K |
|
122
Invesco S&P 500 Equal Weight ETF
RSP
$73.5B
| $215K | 0.02% |
+1,200
| New | +$215K |
|
123
Vanguard Small-Cap Growth ETF
VBK
$20B
| $213K | 0.02% |
796
-40
| -5% | -$10.7K |
|
124
Northrop Grumman
NOC
$83.2B
| $212K | 0.02% |
+400
| New | +$212K |
|
125
Thermo Fisher Scientific
TMO
$183B
| $210K | 0.02% |
+340
| New | +$210K |
|